Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
SoSe 2025
- Wahlfach: Spezielle interdisziplinäre Intensivmedizin (5. FS WP)
- Vorlesung Neurologie (9. FS WA)
- Zelluläre und molekulare Grundlagen neurologischer Erkrankungen - vom Krankenbett ins Labor und zurück
- Neuroscience Lab Seminar
- Wahlfach: Molekularbiologie
- Praktikum der Neurologie (9. FS PV)
- Differenzialdiagnose Seltene Erkrankungen
- Neurowissenschaftliches Seminar
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
- Vorlesung Neurologie (9. FS WA)
- Differenzialdiagnose Seltene Erkrankungen
- Wahlfach: Molekularbiologie
- Wahlfach: Spezielle interdisziplinäre Intensivmedizin (5. FS WP)
- Zelluläre und molekulare Grundlagen neurologischer Erkrankungen - vom Krankenbett ins Labor und zurück
- Praktikum der Neurologie (9. FS PV)
- Neuroscience Lab Seminar
- Neurowissenschaftliches Seminar
-
SoSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Assessing the symptom control provided by ravulizumab or efgartigimod in myasthenia gravis : An evaluation of the patient experience of two different treatment approachesIn: Current Medical Research and Opinion 2025 , in pressDOI (Open Access)
-
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survivalIn: Annals of Hematology , Jg. 104 2025, Nr. 3, S. 1777 – 1788DOI (Open Access)
-
Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)In: BMC Research Notes , Jg. 18 2025, Nr. 1, 145DOI (Open Access)
-
Triiodothyronine treatment in mice improves stroke outcome and reduces blood–brain barrier damageIn: European Thyroid Journal , Jg. 14 2025, Nr. 1, e240143DOI (Open Access)
-
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2In: Journal of Neurology , Jg. 271 2024, Nr. 5, S. 2787 – 2797DOI (Open Access)
-
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophyIn: Acta Neuropathologica , Jg. 147 2024, Nr. 1, 53DOI (Open Access)
-
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatmentIn: Nature Communications , Jg. 15 2024, Nr. 1, 4120DOI (Open Access)
-
Clinical Effectiveness of Newborn Screening for Spinal Muscular AtrophyIn: JAMA Pediatrics , Jg. 178 2024, Nr. 6, S. 540 – 547
-
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy : A Nonrandomized Controlled TrialIn: Obstetrical and Gynecological Survey , Jg. 79 2024, Nr. 12, S. 702 – 704
-
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survivalIn: Haematologica / The Hematology Journal , Jg. 109 2024, Nr. 1, S. 220 – 230DOI (Open Access)
-
Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy : Systematic Review and Meta-analysisIn: Neurology and Therapy , Jg. 13 2024, Nr. 5, S. 1483 – 1504DOI (Open Access)
-
Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting : a 12-month multicenter cohort study from the German early access programIn: eClinicalMedicine , Jg. 69 2024, 102495DOI (Open Access)
-
Fatigue and associated factors in myasthenia gravis : a nationwide registry studyIn: Journal of Neurology , Jg. 271 2024, Nr. 8, S. 5665 – 5670DOI (Open Access)
-
Gene replacement therapy in spinal muscular atrophy: filling the data gapsIn: The Lancet Regional Health - Europe , Jg. 37 2024, 100822DOI (Open Access)
-
Iatrogenic botulism after intragastric botulinum neurotoxin injections – a major outbreakIn: Neurological Research and Practice , Jg. 6 2024, Nr. 1, 52DOI (Open Access)
-
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy : a prospective European multinational observational studyIn: The Lancet Regional Health - Europe , Jg. 39 2024, 100862DOI, Online Volltext (Open Access)
-
Oral functions in adult persons with spinal muscular atrophy compared to a healthy control group : a prospective cross-sectional study with a multimodal approachIn: Orphanet Journal of Rare Diseases , Jg. 19 2024, Nr. 1DOI (Open Access)
-
Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis : Protocol of a German multicentre studyIn: Neurological Research and Practice , Jg. 6 2024, Nr. 1, 34DOI (Open Access)
-
Performance fatigability in adults with spinal muscular atrophy treated long-term with nusinersenIn: Muscle & Nerve , Jg. 70 2024, Nr. 6, S. 1223 – 1229DOI (Open Access)
-
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairmentIn: Journal of Neurology , Jg. 271 2024, Nr. 5, S. 2649 – 2657DOI (Open Access)
-
Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular AtrophyIn: Journal of Neuromuscular Diseases , Jg. 11 2024, Nr. 5, S. 1049 – 1065DOI (Open Access)
-
Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophyIn: Journal of Neurology , Jg. 271 2024, Nr. 10, S. 7000 – 7011DOI (Open Access)
-
Versorgung von Patienten mit kardialer Amyloidose : Konsensuspapier der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK), AG 40 Onkologische Kardiologie, und der Deutschen Gesellschaft für Hämatologie und medizinische Onkologie e. V. (DGHO), der Deutschen Gesellschaft für Neurologie e. V. (DGN) und der Deutschen Gesellschaft für Nephrologie e. V. (DGfN)In: Die Kardiologie , Jg. 18 2024, Nr. 1, S. 36 – 43DOI (Open Access)
-
254th ENMC international workshop. Formation of a European network to initiate a European data collection, along with development and sharing of treatment guidelines for adult SMA patients : Virtual meeting 28 – 30 January 2022In: Neuromuscular Disorders , Jg. 33 2023, Nr. 6, S. 511 – 522
-
Analysis of Free Circulating Messenger Ribonucleic Acids in Serum Samples from Late-Onset Spinal Muscular Atrophy Patients Using nCounter NanoString TechnologyIn: Cells , Jg. 12 2023, Nr. 19, 2374DOI, Online Volltext (Open Access)
-
Benign peripheral nerve sheath tumors : an interdisciplinary diagnostic and therapeutic challengeIn: Neurosurgical Review , Jg. 46 2023, Nr. 1, S. 205DOI (Open Access)
-
Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency : Case ReportIn: Journal of Clinical Immunology , Jg. 43 2023, Nr. 7, S. 1597 – 1602DOI (Open Access)
-
Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutationsIn: Brain Communications , Jg. 5 2023, Nr. 2, fcad087DOI (Open Access)
-
Closing the Gap : Detection of 5q-Spinal Muscular Atrophy by Short-Read Next-Generation Sequencing and Unexpected Results in a Diagnostic Patient CohortIn: Journal of Neuromuscular Diseases , Jg. 10 2023, Nr. 5, S. 835 – 846DOI (Open Access)
-
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosisIn: Journal of Neurology , Jg. 270 2023, Nr. 7, S. 3483 – 3491DOI (Open Access)
-
Corneal confocal microscopy reveals small nerve fibre loss correlating with motor function in adult spinal muscular atrophyIn: European Journal of Neurology , Jg. 30 2023, Nr. 9, S. 2821 – 2827DOI (Open Access)
-
Economic evaluation of Motor Neuron Diseases : a nationwide cross-sectional analysis in GermanyIn: Journal of Neurology , Jg. 270 2023, Nr. 10, S. 4922 – 4938.DOI (Open Access)
-
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophyIn: Brain: A Journal of Neurology , Jg. 146 2023, Nr. 2, S. 668 – 677DOI (Open Access)
-
Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM StudyIn: Journal of Fungi , Jg. 9 2023, Nr. 5, 569DOI, Online Volltext (Open Access)
-
Guideline for the management of myasthenic syndromesIn: Therapeutic Advances in Neurological Disorders , Jg. 16 2023 , in pressDOI (Open Access)
-
Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers : A Prospective, Cross-Sectional, Multi-Center AnalysisIn: Brain Sciences , Jg. 13 2023, Nr. 1, 110DOI (Open Access)
-
Improvements in Walking Distance during Nusinersen Treatment : A Prospective 3-year SMArtCARE Registry StudyIn: Journal of Neuromuscular Diseases , Jg. 10 2023, Nr. 1, S. 29 – 40DOI (Open Access)
-
Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophyIn: Brain: A Journal of Neurology , Jg. 146 2023, Nr. 4, S. 1388 – 1402
-
Objective measurement of oral function in adults with spinal muscular atrophyIn: Orphanet Journal of Rare Diseases , Jg. 18 2023, Nr. 1, 103DOI (Open Access)
-
Quantitative ⁹⁹mTc-DPD-SPECT/CT assessment of cardiac amyloidosisIn: Journal of Nuclear Cardiology , Jg. 30 2023, Nr. 1, S. 101 – 111DOI (Open Access)
-
Radiation dose and fluoroscopy time of aneurysm coiling in patients with unruptured and ruptured intracranial aneurysms as a function of aneurysm size, location, and patient ageIn: Neuroradiology , Jg. 65 2023, Nr. 3, S. 637 – 644DOI (Open Access)
-
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravisIn: Journal of Neurology , Jg. 270 2023, Nr. 1, S. 1 – 12DOI (Open Access)
-
Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophyIn: Acta Neuropathologica , Jg. 145 2023, Nr. 5, S. 611 – 635DOI (Open Access)
-
Update zur medikamentösen Behandlung der spinalen MuskelatrophieIn: Der Nervenarzt , Jg. 94 2023, Nr. 6, S. 488 – 493
-
„Essener Transitionsmodell“ bei neuromuskulären ErkrankungenIn: Der Nervenarzt , Jg. 94 2023, Nr. 2, S. 129 – 135DOI (Open Access)
-
A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype : a case reportIn: BMC Neurology , Jg. 22 2022, Nr. 1, 469DOI, Online Volltext (Open Access)
-
ALSFRS-R-SE : An adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scaleIn: Neurological Research and Practice , Jg. 4 2022, Nr. 1, 60DOI (Open Access)
-
Assessment of Health-Related Quality of Life in Adult Spinal Muscular Atrophy Under Nusinersen Treatment : A Pilot StudyIn: Frontiers in Neurology , Jg. 12 2022, 812063DOI, Online Volltext (Open Access)
-
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis : A retrospective multicentre cohort studyIn: European Journal of Cancer (EJC) , Jg. 175 2022, S. 224 – 235DOI (Open Access)
-
Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosisIn: ESC Heart Failure , Jg. 9 2022, Nr. 3, S. 1740 – 1748DOI, Online Volltext (Open Access)
-
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosisIn: Annals of Clinical and Translational Neurology , Jg. 9 2022, Nr. 6, S. 853 – 863DOI, Online Volltext (Open Access)
-
Correction to : Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in GermanyIn: Orphanet Journal of Rare Diseases , Jg. 17 2022, Nr. 1, 387DOI (Open Access)
-
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitisIn: Data in Brief , Jg. 45 2022, 108649DOI (Open Access)
-
Eculizumab versus rituximab in generalised myasthenia gravisIn: Journal of Neurology, Neurosurgery and Psychiatry 2022 , jnnp-2021-328665DOI (Open Access)
-
Essen transition model for neuromuscular diseasesIn: Neurological Research and Practice , Jg. 4 2022, Nr. 1, 41DOI (Open Access)
-
Genetisch basierte Therapien bei spinaler MuskelatrophieIn: Der Nervenarzt , Jg. 93 2022, Nr. 6, S. 549 – 556
-
Immunological consequences of cladribine treatment in multiple sclerosis : A real-world studyIn: Multiple Sclerosis and Related Disorders , Jg. 64 2022, 103931DOI (Open Access)
-
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment : A prospective 3-years SMArtCARE registry studyIn: Orphanet Journal of Rare Diseases , Jg. 17 2022, Nr. 1, 384DOI (Open Access)
-
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patientsIn: Journal of Neuroinflammation , Jg. 19 2022, Nr. 1, 89DOI (Open Access)
-
Induction of Survival of Motor Neuron (SMN) Protein Deficiency in Spinal Astrocytes by Small Interfering RNA as an In Vitro Model of Spinal Muscular AtrophyIn: Cells , Jg. 11 2022, Nr. 3, 558DOI, Online Volltext (Open Access)
-
Prevalence and predictors of neurological manifestations in systemic AL amyloidosisIn: Journal of the Neurological Sciences , Jg. 440 2022, 120341
-
Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular AtrophyIn: Human Gene Therapy , Jg. 33 2022, Nr. 17-18, S. 968 – 976
-
Radiation Exposure During Diagnostic and Therapeutic Angiography of Carotid-cavernous Fistula : A Retrospective Single Center Observational StudyIn: Clinical Neuroradiology , Jg. 32 2022, Nr. 1, S. 117 – 122DOI (Open Access)
-
Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in GermanyIn: Orphanet Journal of Rare Diseases , Jg. 17 2022, Nr. 1, 276DOI, Online Volltext (Open Access)
-
Total Plasma Exchange in Neuromuscular Junction Disorders : A Single-Center, Retrospective Analysis of the Efficacy, Safety and Potential Diagnostic Properties in Doubtful DiagnosisIn: Journal of Clinical Medicine (JCM) , Jg. 11 2022, Nr. 15, 4383DOI (Open Access)
-
Treatment of Adult Spinal Muscular Atrophy : Overview and Recent DevelopmentsIn: Current Pharmaceutical Design , Jg. 28 2022, Nr. 11, S. 892 – 898
-
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophyIn: Annals of Clinical and Translational Neurology , Jg. 9 2022, Nr. 3, S. 351 – 362DOI (Open Access)
-
¹⁸F-flutemetamol positron emission tomography in cardiac amyloidosisIn: Journal of Nuclear Cardiology , Jg. 29 2022, Nr. 2, S. 779 – 789DOI (Open Access)
-
A Sum Score to Define Therapy-Refractory Myasthenia Gravis : A German ConsensusIn: Journal of Central Nervous System Disease , Jg. 13 2021, S. 117957352198915DOI (Open Access)
-
Assessment of bulbar function in adult patients with 5q‐sma type 2 and 3 under treatment with nusinersenIn: Brain Sciences , Jg. 11 2021, Nr. 9, 1244DOI, Online Volltext (Open Access)
-
Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatmentIn: Multiple Sclerosis Journal , Jg. 27 2021, Nr. 12, S. 1960 – 1964DOI (Open Access)
-
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy : the German/Austrian position and review of the literatureIn: Journal of Neurology , Jg. 268 2021, Nr. 10, S. 3610 – 3625DOI (Open Access)
-
Cisplatin-induced activation and functional modulation of satellite glial cells lead to cytokine-mediated modulation of sensory neuron excitabilityIn: Experimental Neurology , Jg. 341 2021, 113695
-
Cognitive impairment in adult patients with 5q-associated spinal muscular atrophyIn: Brain Sciences , Jg. 11 2021, Nr. 9, 1184DOI, Online Volltext (Open Access)
-
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapyIn: eNeurologicalSci , Jg. 22 2021, 100324DOI (Open Access)
-
Gut bacterial microbiota in patients with myasthenia gravis : Results from the MYBIOM studyIn: Therapeutic Advances in Neurological Disorders , Jg. 14 2021 , in pressDOI, Online Volltext (Open Access)
-
Immunotherapies in chronic adhesive arachnoiditis : A case series and literature reviewIn: eNeurologicalSci , Jg. 24 2021, 100350DOI, Online Volltext (Open Access)
-
Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvementIn: European Journal of Haematology , Jg. 107 2021, Nr. 4, S. 449 – 457DOI (Open Access)
-
Modulation of glutamate transporter eaat1 and inward-rectifier potassium channel kir₄.₁ expression in cultured spinal cord astrocytes by platinum-based chemotherapeuticsIn: International Journal of Molecular Sciences (IJMS) , Jg. 22 2021, Nr. 12, 6300DOI, Online Volltext (Open Access)
-
Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parametersIn: Journal of Neurology , Jg. 268 2021, Nr. 12, S. 4667 – 4679DOI (Open Access)
-
Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype : A case series with literature reviewIn: Molecular Genetics & Genomic Medicine , Jg. 9 2021, Nr. 12, e1581DOI, Online Volltext (Open Access)
-
Reply to: Minimal detectable change and minimal clinically important differences in spinal muscular atrophy patientsIn: European Journal of Neurology , Jg. 28 2021, Nr. 6, S. e42 – e43
-
Risdiplam : Aus ExpertensichtIn: Psychopharmakotherapie , Jg. 28 2021, Nr. 5, S. 205 – 206(Open Access)
-
Risdiplam : Aus ExpertensichtIn: Arzneimitteltherapie (AMT) , Jg. 39 2021, Nr. 9, S. 293 – 294
-
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatmentIn: Annals of Clinical and Translational Neurology , Jg. 8 2021, Nr. 5, S. 1049 – 1063DOI (Open Access)
-
Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodiesIn: Neurological Research and Practice , Jg. 3 2021, Nr. 1, 30DOI (Open Access)
-
TDP-43 as structure-based biomarker in amyotrophic lateral sclerosisIn: Annals of Clinical and Translational Neurology , Jg. 8 2021, Nr. 1, S. 271 – 277DOI (Open Access)
-
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersenIn: European Journal of Neurology , Jg. 28 2021, Nr. 8, S. 2582 – 2595DOI (Open Access)
-
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapyIn: Therapeutic Advances in Neurological Disorders , Jg. 14 2021 , in pressDOI (Open Access)
-
Activation and functional modulation of satellite glial cells by oxaliplatin lead to hyperexcitability of sensory neurons in vitroIn: Molecular and Cellular Neuroscience (MCN) , Jg. 105 2020, 103499
-
Compromised Hippocampal Neuroplasticity in the Interferon-α and Toll-like Receptor-3 Activation-Induced Mouse Depression ModelIn: Molecular Neurobiology , Jg. 57 2020, Nr. 7, S. 3171 – 3182DOI (Open Access)
-
Diagnosing cardiac amyloidosis in every-day practice : A practical guide for the cardiologistIn: International Journal of Cardiology (IJC) Heart & Vasculature , Jg. 28 2020, S. 100519DOI (Open Access)
-
Fatigue in adults with spinal muscular atrophy under treatment with nusinersenIn: Scientific Reports , Jg. 10 2020, Nr. 1, S. 11069DOI (Open Access)
-
Genotype-phenotype correlation in a novel ABHD12 mutation underlying PHARC syndromeIn: Journal of the Peripheral Nervous System , Jg. 25 2020, Nr. 2, S. 112 – 116
-
Measuring Outcomes in Adults with Spinal Muscular Atrophy : Challenges and Future Directions - Meeting ReportIn: Journal of Neuromuscular Diseases , Jg. 7 2020, Nr. 4, S. 523 – 534
-
Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophyIn: European Journal of Neurology , Jg. 27 2020, Nr. 12, S. 2586 – 2594DOI (Open Access)
-
Nusinersen in adults with 5q spinal muscular atrophy : A non-interventional, multicentre, observational cohort studyIn: The Lancet Neurology , Jg. 19 2020, Nr. 4, S. 317 – 325
-
Platinum-based drugs cause mitochondrial dysfunction in cultured dorsal root ganglion neuronsIn: International Journal of Molecular Sciences (IJMS) , Jg. 21 2020, Nr. 22, S. 8636DOI, Online Volltext (Open Access)
-
Publisher Correction to: 18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosisIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 47 2020, Nr. 13, S. 3196DOI (Open Access)
-
¹⁸F-florbetaben positron computed tomography detects cardiac involvement in systemic AA amyloidosisIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 47 2020, Nr. 13, S. 3186 – 3187DOI (Open Access)
-
Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular AtrophyIn: Frontiers in Neurology , Jg. 10 2019, S. 1166DOI, Online Volltext (Open Access)
-
Efficacy and safety of IVIG in CIDP : Combined data of the PRIMA and PATH studiesIn: Journal of the Peripheral Nervous System , Jg. 24 2019, Nr. 1, S. 48 – 55DOI (Open Access)
-
Metastatic Merkel cell carcinoma and myasthenia gravis : contraindication for therapy with immune checkpoint inhibitors?In: Journal for ImmunoTherapy of Cancer , Jg. 7 2019, Nr. 1, S. 141DOI, Online Volltext (Open Access)
-
Neurofilament Heavy Chain and Tau Protein Are Not Elevated in Cerebrospinal Fluid of Adult Patients with Spinal Muscular Atrophy during Loading with NusinersenIn: International Journal of Molecular Sciences (IJMS) , Jg. 20 2019, Nr. 21, S. 5397DOI, Online Volltext (Open Access)
-
Prognostic factors in ALS : a comparison between Germany and ChinaIn: Journal of Neurology , Jg. 266 2019, Nr. 6, S. 1516 – 1525
-
Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophyIn: Neuroradiology , Jg. 61 2019, Nr. 5, S. 565 – 574
-
Reply: : Adult-onset distal spinal muscular atrophy: A new phenotype associated with KIF5A mutationsIn: Brain: A Journal of Neurology , Jg. 142 2019, Nr. 12, S. E67DOI (Open Access)
-
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy : Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra studyIn: Journal of the Peripheral Nervous System , Jg. 24 2019, Nr. 1, S. 72 – 79DOI (Open Access)
-
Spinale Muskelatrophie – Expertenempfehlungen zur Behandlung von erwachsenen Patienten mit NusinersenIn: Fortschritte der Neurologie - Psychiatrie (FDN) , Jg. 87 2019, Nr. 12, S. 703 – 710
-
Therapieevaluation bei Patienten mit 5q-assoziierter spinaler Muskelatrophie : Erfahrungen aus der klinischen PraxisIn: Der Nervenarzt , Jg. 90 2019, Nr. 4, S. 343 – 351
-
Understanding the burden of refractory myasthenia gravisIn: Therapeutic Advances in Neurological Disorders , Jg. 12 2019DOI (Open Access)
-
CIDP, myasthenia gravis, and membranous glomerulonephritis - three autoimmune disorders in one patient : a case reportIn: BMC Neurology , Jg. 18 2018, 113DOI (Open Access)
-
Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophyIn: Therapeutic Advances in Neurological Disorders , Jg. 11 2018DOI (Open Access)
-
Oxaliplatin Modulates the Characteristics of Voltage-Gated Calcium Channels and Action Potentials in Small Dorsal Root Ganglion Neurons of RatsIn: Molecular Neurobiology , Jg. 55 2018, Nr. 12, S. 8842 – 8855
-
Cisplatin alters the function and expression of N-type voltage-gated calcium channels in the absence of morphological damage of sensory neurons.In: Molecular Pain , Jg. 13 2017, 1744806917746565DOI (Open Access)
-
Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neuronsIn: Experimental Neurology , Jg. 288 2017, S. 62 – 74
-
Early platelet and leukocyte decline in patients with neuroinflammatory disorders after intravenous immunoglobulinsIn: European Journal of Neurology , Jg. 24 2017, Nr. 4, S. 638 – 644
-
Intrathecal Resiniferatoxin Modulates TRPV1 in DRG Neurons and Reduces TNF-Induced Pain-Related BehaviorIn: Mediators of Inflammation 2017, 2786427DOI (Open Access)
-
Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class IIIn: Scientific Reports , Jg. 7 2017, 12518DOI (Open Access)
-
Short Latency Gray Matter Changes in Voxel-Based Morphometry following High Frequent Visual StimulationIn: Neural Plasticity , Jg. 2017 2017, S. 1397801DOI (Open Access)
-
Clinical features of neuromuscular disorders in patients with N-type voltage-gated calcium channel antibodiesIn: European Journal of Translational Myology , Jg. 26 2016, Nr. 4, S. 301 – 306DOI (Open Access)
-
Diagnostik und Therapie Chemotherapie-induzierter Polyneuropathien: Update 2016In: Aktuelle Neurologie , Jg. 43 2016, Nr. 3, S. 171 – 178
-
Miller-Fisher-Syndrom und Bickerstaff-Enzephalitis: Das Anti-GQ1b-Syndrom : 2 Seiten einer MedailleIn: Aktuelle Neurologie , Jg. 43 2016, Nr. 6, S. 380 – 384
-
Calcitonin Gene-Related Peptide und MigräneIn: Arzneimitteltherapie (AMT) , Jg. 33 2015, Nr. 6, S. 181 – 184
-
Modulation of Voltage-Gated Sodium Channels by Activation of Tumor Necrosis Factor Receptor-1 and Receptor-2 in Small DRG Neurons of RatsIn: Mediators of Inflammation 2015, 124942DOI (Open Access)
-
Anodal transcranial direct current stimulation alleviates pain in trigeminal neuralgiaIn: The Journal of Headache and Pain , Jg. 15 2014, Nr. Suppl.1, S. E21DOI (Open Access)
-
First report of a rare mutation in a Polish patient with painful late-onset transthyretin amyloidosisIn: Journal of the Neurological Sciences , Jg. 346 2014, Nr. 1-2, S. 331 – 332
-
Icilin reduces voltage-gated calcium channel currents in naïve and injured DRG neurons in the rat spinal nerve ligation modelIn: Brain Research , Jg. 1557 2014, S. 171 – 179
-
Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgiaIn: The Journal of Headache and Pain , Jg. 15 2014, S. 78DOI (Open Access)
-
Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neuronsIn: European Journal of Pain , Jg. 17 2013, Nr. 6, S. 881 – 892
-
Pallidal deep brain stimulation relieves camptocormia in primary dystoniaIn: Journal of Neurology , Jg. 260 2013, Nr. 7, S. 1833 – 1837
-
Voxel Based Morphometry Showing Acute Alteration in a Visual ParadigmIn: Neurology , Jg. 78 2012, Nr. Suppl. 1, S. P01.195
-
Additive inhibitory effects of calcitonin and capsaicin on voltage activated calcium channel currents in nociceptive neurones of ratIn: Brain Research Bulletin , Jg. 85 2011, Nr. 1-2, S. 75 – 80
-
Differenzialdiagnostik seltener SchlaganfallursachenIn: Aktuelle Neurologie , Jg. 38 2011, Nr. 3, S. 134 – 149
-
Increased miRNA17 and miRNA20a expression in patients with development of acute graft-versus-host disease after allogeneic stem cell transplantationIn: Bone Marrow Transplantation , Jg. 46 2011, Nr. Suppl. 1, S. S243 – S244
-
A high CSF signal on FLAIR : It is not always bloodIn: The Neuroradiology Journal (NRJ) , Jg. 23 2010, Nr. 4, S. 389 – 392
-
Anti-allodynic effect of the flavonoid myricetin in a rat model of neuropathic pain : Involvement of p38 and protein kinase C mediated modulation of Ca²⁺ channelsIn: European Journal of Pain , Jg. 14 2010, Nr. 10, S. 992 – 998
-
Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer painIn: Neuroscience , Jg. 169 2010, Nr. 1, S. 463 – 474
-
Hitzefasern werden durch Entzündungsstoffe empfindlicherIn: Der Schmerz , Jg. 24 2010, Nr. 1, S. 69 – 70
-
Myricetin reduces voltage activated potassium channel currents in DRG neurons by a p38 dependent mechanismIn: Brain Research Bulletin , Jg. 83 2010, Nr. 5, S. 292 – 296
-
Sensitization of voltage activated calcium channel currents for capsaicin in nociceptive neurons by tumor-necrosis-factor-alphaIn: Brain Research Bulletin , Jg. 81 2010, Nr. 1, S. 157 – 163
-
Editorial: Spinal Muscular Atrophy : Evolutions and Revolutions of Modern TherapyIn: Frontiers in Neurology , Jg. 11 2020, 783DOI (Open Access)
-
Gain or Amplification of 1q21 in Systemic Light Chain Amyloidosis Is Associated with Advanced Mayo Stage, Plasma Cell Disease and Worse Overall SurvivalIn: Blood The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA , Jg. 144 2024, Nr. Supplement 1, S. 3309DOI (Open Access)
-
SMArtCARE : Real-world-data collection of patients with spinal muscular atrophy
25th (Virtuell) Congress of the World Muscle Society ; WMS 2020 ; 28 September - 2 October 2020, Halifax, Canada,In: Neuromuscular Disorders , Jg. 30 2020, Nr. Supplement 1, S. S97 -
Cinnamaldehyde reduces voltage-gated calcium channel currents in dorsal root ganglion neurons of rats TRPA1-independentlyIn: Acta Physiologica , Jg. 216 2016, Nr. Suppl. 707, Special Issue: Abstracts of the 95th Annual Meeting of the German Physiological Society, 3–5 March 2016, S. 89
-
Cisplatin-induced neuropathic pain is mediated by N-type voltage-gated calcium channelsIn: Acta Physiologica , Jg. 216 2016, Nr. Suppl. 707, Special Issue: Abstracts of the 95th Annual Meeting of the German Physiological Society, 3–5 March 2016, S. 87
-
Oxaliplatin modulates subtypes of voltage-gated calcium channel currents in small DRG neuronsIn: Acta Physiologica , Jg. 216 2016, Nr. Suppl. S707, Special Issue: Abstracts of the 95th Annual Meeting of the German Physiological Society, 3–5 March 2016, S. 88 – 89
-
Oxaliplatin modulates voltage-gated calcium channel currents in small DRG neurons
94th Annual Meeting of the German Physiological Society, 5‐7 March 2015, Magdeburg, Germany,In: Acta Physiologica , Jg. 213 2015, Nr. Suppl. 699, S. 68 -
Subtype-dependent modulation of voltage-gated calcium channels in small dorsal root ganglion neurons by cisplatin
94th Annual Meeting of the German Physiological Society, 5‐7 March 2015, Magdeburg, Germany,In: Acta Physiologica , Jg. 213 2015, Nr. Suppl. 699, S. 69 -
Anodal transcranial direct current stimulation alleviates pain in trigeminal neuralgia
Joint Congress of European Neurology, Istanbul, Turkey, May 2014,In: European Journal of Neurology , Jg. 21 2014, Nr. Suppl. 1, S. 52 -
Anodal transcranial direct current stimulation alleviates pain in trigeminal neuralgia
Joint Congress of European Neurology 31 May–3 June 2014 Istanbul, Turkey,In: Journal of Neurology , Jg. 261 2014, Nr. Suppl.1, S. 39 -
Cisplatin reduces voltage gated calcium channel currents in small dorsal root ganglion neurons
93rd Annual Meeting of the German Physiological Society, 13‐15 March 2014, Mainz, Germany,In: Acta Physiologica , Jg. 210 2014, Nr. S695, S. 140 -
Increased miRNA17 and miRNA20a expression in patients with development of acute Graft-versus-host disease after allogeneic stem cell transplantation
Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Onkologie Jahrestagung, Basel, September-Oktober 2011,In: Onkologie , Jg. 34 2011, Nr. Suppl. 6, S. 278 -
Ionenkanäle in der Genese neuropathischer SchmerzsyndromeDuisburg, Essen 2014
-
Assessing the extent of symptom control provided by ravulizumab or efgartigimod in generalised myasthenia gravis
26th World Congress of Neurology (WCN 2023), 15-19 October 2023, Montreal, Canada,In: Journal of the Neurological Sciences , Jg. 455 2023, Nr. Supplement, S. 147 -
Exploring the construct validity and reliability of sensor-based measurements derived from active motor assessments in adult walkers with SMA
28th International Congress of the World Muscle Society, 3-7 October 2023, Charleston, South Carolina, USA,In: Neuromuscular Disorders , Jg. 33 2023, Nr. Supplement 1, S. S134 -
Long-term effect of nusinersen treatment on motor, respiratory and bulbar function in children with SMA type 1 : A 3-year SMArtCARE registry study
27th International Congress of the World Muscle Society, 11 - 15 October 2022, Halifax, Nova Scotia, Canada,In: Neuromuscular Disorders , Jg. 32 2022, Nr. Supplement 1, S. S63 – S64DOI (Open Access)